Intramuscular Aripiprazole in the Acute Management of Psychomotor Agitation

An improved simple LC–MS/MS method for the measurement of serum aripiprazole and its major metabolite

(2012) Matteo Caloro et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Serum concentrations of paliperidone versus risperidone and clinical effects

(2010) Yasmin Nazirizadeh et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Does Inclusion of a Placebo Arm Influence Response to Active Antidepressant Treatment in Randomized Controlled Trials?

(2010) Mark Sinyor et al.   JOURNAL OF CLINICAL PSYCHIATRY

Effects of the CYP2D6*10 Allele on the Steady-State Plasma Concentrations of Aripiprazole and Its Active Metabolite, Dehydroaripiprazole, in Japanese Patients With Schizophrenia

(2010) Takeshi Suzuki et al.   THERAPEUTIC DRUG MONITORING

Aripiprazole

(2009) Shubhra Mace et al.   CNS DRUGS

Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study

(2009) Jun Soo Kwon et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Large Intraindividual Variability of Olanzapine Serum Concentrations in Adolescent Patients

(2009) Christian J Bachmann et al.   THERAPEUTIC DRUG MONITORING

The Relationship Between the Response of Clinical Symptoms and Plasma Olanzapine Concentration, Based on Pharmacogenetics

(2009) Motohiro Nozawa et al.   THERAPEUTIC DRUG MONITORING

Serum Levels of Risperidone and Its Metabolite, 9-Hydroxyrisperidone: Correlation Between Drug Concentration and Clinical Response

(2009) Alfonso M Lostia et al.   THERAPEUTIC DRUG MONITORING

Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review

(2009) Konstantinos N Fountoulakis et al.   Annals of General Psychiatry

Conventional intramuscular sedatives versus ziprasidone for severe agitation in adolescents: case-control study

(2009) William C Jangro et al.   Child and Adolescent Psychiatry and Mental Health

Brain and Plasma Pharmacokinetics of Aripiprazole in Patients With Schizophrenia: An [18F]Fallypride PET Study

(2008) Gerhard Gründer et al.   AMERICAN JOURNAL OF PSYCHIATRY

Pharmacokinetics and Tolerability of Intramuscular, Oral and Intravenous Aripiprazole??in Healthy Subjects and in??Patients??with Schizophrenia

(2008) David W Boulton et al.   CLINICAL PHARMACOKINETICS

Intramuscular Aripiprazole

(2008) Mark Sanford et al.   CNS DRUGS

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

(2008) Stefan Leucht et al.   LANCET

Serum levels of aripiprazole and dehydroaripiprazole, clinical response and side effects

(2008) Katrin M. Kirschbaum et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY